美国 · 股市与财经 · MarketWatch
Bristol Myers Squibb Says FDA Approves Heart Disease Treatment Camzyos for Pediatric Patients
Bristol Myers Squibb said the Food and Drug Administration approved Camzyos to treat symptomatic obstructive hypertrophic cardiomyopathy in adults and pediatric patients weighing…
在 MarketWatch 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketwatch.com)
